Differential effects of two major neurosteroids on cerebellar and cortical GABAA receptor binding and function

G. Maksay, László Fodor

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cerebellar and cerebrocortical A-type γ-aminobutyric acid (GABA A) receptors were examined in mice and rats. In wild-type mouse cerebellum, the agonists GABA and gaboxadol exerted heterogeneous displacement of [3H]ethynylbicycloorthobenzoate (EBOB) binding with nanomolar and submicromolar affinities. In mouse cerebella lacking α6 subunits (α6KO), nanomolar displacement by GABA agonists was absent, while micromolar displacement was potentiated to 12-fold by 0.3 μM 5α-tetrahydrodeoxycorticosterone (5α-THDOC). In α6KO cerebellum, 60% of [3H]EBOB binding was neurosteroid-insensitive, while 5α-THDOC elicited enhancement with EC50 = 150 nM instead of nanomolar displacement. In conclusion, nanomolar displacement of cerebellar [3H]EBOB binding by GABA agonists and neurosteroids can be attributed to GABAA receptors containing α6 and δ subunits. In contrast, [3H]EBOB binding to rat cerebral cortex was affected by allopregnanolone and 5α-THDOC in bidirectional manner with nanomolar enhancement (EC50 ~ 80 nM) and micromolar displacement. Nonequilibrium binding conditions with decreased incubation time tripled the maximal enhancement of [3H]EBOB binding by 5α-THDOC. 5ß-THDOC enhanced the cortical [3H]EBOB binding with EC 50 ~ 0.5 μM and it attenuated bidirectional modulation by 5α-THDOC. Allopregnanolone and 5α-THDOC produced biphasic enhancements of chloride currents elicited by 1 μM GABA in cerebellar granule cells, for 5α-THDOC with EC50,1 ~ 16 nM and EC50,2 ~ 1.3 μM. Differences in peak current enhancements in the absence minus presence of 0.1 mM furosemide corresponding to α6ßδ GABA A receptors were augmented only by micromolar 5α-THDOC while the difference curve for allopregnanolone was polyphasic as without furosemide. Consequently, these neurosteroids differentially affected the binding and function of various GABAA receptor populations.

Original languageEnglish
Pages (from-to)94-101
Number of pages8
JournalEuropean Journal of Pharmacology
Volume650
Issue number1
DOIs
Publication statusPublished - Jan 10 2011

Fingerprint

GABA-A Receptors
Neurotransmitter Agents
Pregnanolone
GABA Agonists
Cerebellum
Furosemide
Aminobutyrates
tetrahydrodeoxycorticosterone
Cerebral Cortex
gamma-Aminobutyric Acid
Chlorides

Keywords

  • α6ßδ GABA receptor
  • α6KO mouse
  • 5α/ß-THDOC
  • [H]EBOB binding
  • Allopregnanolone
  • Gaboxadol

ASJC Scopus subject areas

  • Pharmacology

Cite this

Differential effects of two major neurosteroids on cerebellar and cortical GABAA receptor binding and function. / Maksay, G.; Fodor, László.

In: European Journal of Pharmacology, Vol. 650, No. 1, 10.01.2011, p. 94-101.

Research output: Contribution to journalArticle

@article{c6279ad18ce342ecb4d51ca44294e013,
title = "Differential effects of two major neurosteroids on cerebellar and cortical GABAA receptor binding and function",
abstract = "Cerebellar and cerebrocortical A-type γ-aminobutyric acid (GABA A) receptors were examined in mice and rats. In wild-type mouse cerebellum, the agonists GABA and gaboxadol exerted heterogeneous displacement of [3H]ethynylbicycloorthobenzoate (EBOB) binding with nanomolar and submicromolar affinities. In mouse cerebella lacking α6 subunits (α6KO), nanomolar displacement by GABA agonists was absent, while micromolar displacement was potentiated to 12-fold by 0.3 μM 5α-tetrahydrodeoxycorticosterone (5α-THDOC). In α6KO cerebellum, 60{\%} of [3H]EBOB binding was neurosteroid-insensitive, while 5α-THDOC elicited enhancement with EC50 = 150 nM instead of nanomolar displacement. In conclusion, nanomolar displacement of cerebellar [3H]EBOB binding by GABA agonists and neurosteroids can be attributed to GABAA receptors containing α6 and δ subunits. In contrast, [3H]EBOB binding to rat cerebral cortex was affected by allopregnanolone and 5α-THDOC in bidirectional manner with nanomolar enhancement (EC50 ~ 80 nM) and micromolar displacement. Nonequilibrium binding conditions with decreased incubation time tripled the maximal enhancement of [3H]EBOB binding by 5α-THDOC. 5{\ss}-THDOC enhanced the cortical [3H]EBOB binding with EC 50 ~ 0.5 μM and it attenuated bidirectional modulation by 5α-THDOC. Allopregnanolone and 5α-THDOC produced biphasic enhancements of chloride currents elicited by 1 μM GABA in cerebellar granule cells, for 5α-THDOC with EC50,1 ~ 16 nM and EC50,2 ~ 1.3 μM. Differences in peak current enhancements in the absence minus presence of 0.1 mM furosemide corresponding to α6{\ss}δ GABA A receptors were augmented only by micromolar 5α-THDOC while the difference curve for allopregnanolone was polyphasic as without furosemide. Consequently, these neurosteroids differentially affected the binding and function of various GABAA receptor populations.",
keywords = "α6{\ss}δ GABA receptor, α6KO mouse, 5α/{\ss}-THDOC, [H]EBOB binding, Allopregnanolone, Gaboxadol",
author = "G. Maksay and L{\'a}szl{\'o} Fodor",
year = "2011",
month = "1",
day = "10",
doi = "10.1016/j.ejphar.2010.10.003",
language = "English",
volume = "650",
pages = "94--101",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Differential effects of two major neurosteroids on cerebellar and cortical GABAA receptor binding and function

AU - Maksay, G.

AU - Fodor, László

PY - 2011/1/10

Y1 - 2011/1/10

N2 - Cerebellar and cerebrocortical A-type γ-aminobutyric acid (GABA A) receptors were examined in mice and rats. In wild-type mouse cerebellum, the agonists GABA and gaboxadol exerted heterogeneous displacement of [3H]ethynylbicycloorthobenzoate (EBOB) binding with nanomolar and submicromolar affinities. In mouse cerebella lacking α6 subunits (α6KO), nanomolar displacement by GABA agonists was absent, while micromolar displacement was potentiated to 12-fold by 0.3 μM 5α-tetrahydrodeoxycorticosterone (5α-THDOC). In α6KO cerebellum, 60% of [3H]EBOB binding was neurosteroid-insensitive, while 5α-THDOC elicited enhancement with EC50 = 150 nM instead of nanomolar displacement. In conclusion, nanomolar displacement of cerebellar [3H]EBOB binding by GABA agonists and neurosteroids can be attributed to GABAA receptors containing α6 and δ subunits. In contrast, [3H]EBOB binding to rat cerebral cortex was affected by allopregnanolone and 5α-THDOC in bidirectional manner with nanomolar enhancement (EC50 ~ 80 nM) and micromolar displacement. Nonequilibrium binding conditions with decreased incubation time tripled the maximal enhancement of [3H]EBOB binding by 5α-THDOC. 5ß-THDOC enhanced the cortical [3H]EBOB binding with EC 50 ~ 0.5 μM and it attenuated bidirectional modulation by 5α-THDOC. Allopregnanolone and 5α-THDOC produced biphasic enhancements of chloride currents elicited by 1 μM GABA in cerebellar granule cells, for 5α-THDOC with EC50,1 ~ 16 nM and EC50,2 ~ 1.3 μM. Differences in peak current enhancements in the absence minus presence of 0.1 mM furosemide corresponding to α6ßδ GABA A receptors were augmented only by micromolar 5α-THDOC while the difference curve for allopregnanolone was polyphasic as without furosemide. Consequently, these neurosteroids differentially affected the binding and function of various GABAA receptor populations.

AB - Cerebellar and cerebrocortical A-type γ-aminobutyric acid (GABA A) receptors were examined in mice and rats. In wild-type mouse cerebellum, the agonists GABA and gaboxadol exerted heterogeneous displacement of [3H]ethynylbicycloorthobenzoate (EBOB) binding with nanomolar and submicromolar affinities. In mouse cerebella lacking α6 subunits (α6KO), nanomolar displacement by GABA agonists was absent, while micromolar displacement was potentiated to 12-fold by 0.3 μM 5α-tetrahydrodeoxycorticosterone (5α-THDOC). In α6KO cerebellum, 60% of [3H]EBOB binding was neurosteroid-insensitive, while 5α-THDOC elicited enhancement with EC50 = 150 nM instead of nanomolar displacement. In conclusion, nanomolar displacement of cerebellar [3H]EBOB binding by GABA agonists and neurosteroids can be attributed to GABAA receptors containing α6 and δ subunits. In contrast, [3H]EBOB binding to rat cerebral cortex was affected by allopregnanolone and 5α-THDOC in bidirectional manner with nanomolar enhancement (EC50 ~ 80 nM) and micromolar displacement. Nonequilibrium binding conditions with decreased incubation time tripled the maximal enhancement of [3H]EBOB binding by 5α-THDOC. 5ß-THDOC enhanced the cortical [3H]EBOB binding with EC 50 ~ 0.5 μM and it attenuated bidirectional modulation by 5α-THDOC. Allopregnanolone and 5α-THDOC produced biphasic enhancements of chloride currents elicited by 1 μM GABA in cerebellar granule cells, for 5α-THDOC with EC50,1 ~ 16 nM and EC50,2 ~ 1.3 μM. Differences in peak current enhancements in the absence minus presence of 0.1 mM furosemide corresponding to α6ßδ GABA A receptors were augmented only by micromolar 5α-THDOC while the difference curve for allopregnanolone was polyphasic as without furosemide. Consequently, these neurosteroids differentially affected the binding and function of various GABAA receptor populations.

KW - α6ßδ GABA receptor

KW - α6KO mouse

KW - 5α/ß-THDOC

KW - [H]EBOB binding

KW - Allopregnanolone

KW - Gaboxadol

UR - http://www.scopus.com/inward/record.url?scp=78649737740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649737740&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2010.10.003

DO - 10.1016/j.ejphar.2010.10.003

M3 - Article

C2 - 20951124

AN - SCOPUS:78649737740

VL - 650

SP - 94

EP - 101

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -